tiprankstipranks
Trending News
More News >

Oren Gilad Insider Profile

4 Followers
Oren Gilad, President & CEO, Director at Aprea Therapeutics, holds 347.42K shares in Aprea Therapeutics (Ticker: APRE). Most recently, Oren Gilad Bought $5,500 shares of Aprea Therapeutics on Apr 04, 2025 for an estimated value of 10.11K.
tipranks
Oren Gilad

Oren Gilad
Aprea Therapeutics (APRE)
President & CEO, Director

Ranked #93,170 out of 102,551 Corporate Insiders

Profitable Transactions

20%
1 out of 5 Profitable Transactions

Average Return

-40.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$577K
100.00%
A breakdown of Oren Gilad's holdings

Insider Roles

Aprea Therapeutics
(APRE)
President & CEO, Director
Roles that Oren Gilad holds in companies

Most Profitable Insider Trade

Stock:
Aprea Therapeutics
(APRE)
Rating:Informative Buy
Date:Apr 04, 2025 - Today
Return:+1.70%
The most profitable trade made by Oren Gilad

Oren Gilad's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aprea Therapeutics
Apr 04, 2025
President & CEO, Director
Informative Buy
10.11K
$576.72K
Success Rate for
APRE
1 out of 5 profitable transactions on
APRE
20%
Average Return for
APRE
Average return per transaction on
APRE
-40.48%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Aug 01, 2022
Uninformative Buy
$0.00
-
$0.00
Mar 13, 2023
Uninformative Buy
$0.00
-
$0.00
Mar 14, 2024
Informative Buy
$14.58K
-
$7.29
-54.80%
Mar 28, 2024
Uninformative Buy
$0.00
-
$0.00
Oct 15, 2024
Informative Buy
$2.97K
-
$2.58
-43.20%
List of latest transactions for each holding click on a transaction to see Oren Gilad's performance on stock

Oren Gilad insider profile FAQ

What is the percentage of profitable transactions made by Oren Gilad?
The percentage of profitable transactions made by Oren Gilad is 20%.
    What is the average return per transaction made by Oren Gilad?
    The average return per transaction made by Oren Gilad is -40.40%.
      What stocks does Oren Gilad hold?
      Oren Gilad holds: APRE stocks.
        What was Oren Gilad’s latest transaction?
        Oren Gilad latest transaction was an Informative Buy of $10.11K.
          What was Oren Gilad's most profitable transaction?
          Oren Gilad’s most profitable transaction was an Informative Buy of APRE stock on April 4, 2025. The return on the trade was 1.70%.
            What is Oren Gilad's role in Aprea Therapeutics?
            Oren Gilad's role in Aprea Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.